Delivery Order SPE2DB24D1205-SPE2DB25FCTSN
Award Date
2/4/25
Potential Completion Date
2/5/25
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S. The contract has a ceiling value of $3,951.88 and a performance period through February 10, 2025. This award is under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide TAMSULOSIN HCL 0.4 MG CAPSULE 1000S to the Department of Defense (DoD). The contract has a firm fixed price of $1,153.51 and an ultimate completion date of June 20, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,280.91 firm fixed-price delivery order is for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, with a period of performance through October 17, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,328.81 fixed-price delivery order is for the supply of 1,000 units of the generic medication Tamsulosin HCL 0.4 mg capsules, to be delivered by September 17, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,081.48 firm fixed-price delivery order is for the supply of 4,565,546,920 units of Tamsulosin Hydrochloride 0.4 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities from...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,520.96, is for the delivery of TAMSULOSIN HCL 0.4 MG CAPSULE 1000S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,765.62 Firm Fixed Price Delivery Order is for the supply of 1,000 units of the prescription medication Tamsulosin HCL 0.4 mg capsules. The contract has an ultimate completion date of December 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award, with ID SPE2DB20D2002|SPE2DB24FL79B, was granted by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of 4565520246 - TAMSULOSIN HCL 0.4 MG CAPSULE 1000S. The contract has a ceiling value of $1,583.28 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of August 21, 2024. The contract was awarded on August 20, 2024, and does not have a set-aside designation. Amerisourcebergen Drug Corp,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,120.82 firm fixed-price delivery order is for the supply of 4,565,255 units of Tamsulosin HCl 0.4 mg capsules to support military and government healthcare requirements. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,342.04 firm fixed-price delivery order is for the supply of 1,000 units of the medication Tamsulosin HCl 0.4 mg capsules. The contract has a period of performance through November 22, 2023 and was awarded on November 21, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...